A Phase I Study of BPM31510 Plus Vitamin K in Subjects With High-Grade Glioma That Has Recurred on a Bevacizumab Containing Regimen

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 12 Aug 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

09 Aug 2021 Status changed from active, no longer recruiting to completed.
08 Jun 2021 Results of molecular pharmacodynamic assessment of BPM 31510-IV treatment in advanced glioblastoma multiforme patients presented at the 57th Annual Meeting of the American Society of Clinical Oncology
02 Jun 2021 According to a Berg Pharma media release, results from this study will be presented at the 2021 American Society of Clinical Oncology Annual Meeting (ASCO).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com